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Abstract
Background: The purpose of this study is to evaluate the role of MRI in musculoskeletal tumours,
especially, in prediction of malignancy & to compare whether the diagnosis made on MRI correlates
with the cytological/histopathological diagnosis.
Methods: 50 consecutive patients presenting in the Outpatient and Inpatient department of the
Department of Orthopaedics or Casualty of Jawaharlal Nehru Medical College and Hospital, AMU,
Aligarh, India were included in this study. They were subjected to MR examination on 1.5 Tesla
superconducting system (MAGNETOM Avanto, Siemens). After localizer sequences, T1W and
STIR images were obtained in longitudinal planes followed by T2W and post contrast T1W images
in axial planes. Additional sequences were taken when required. Various imaging characteristics of
tumours were evaluated statistically and their respective sensitivity and specificity in prediction of
malignancy were obtained.
Results: Features associated with benign diagnosis in a large percentage of cases, are size less than
8 cm, sharp margination, homogeneous T2 signal, absence of oedema, necrosis, calcification and
fluid-fluid levels. Similarly, malignant tumours are commonly associated with presence of irregular
margins, inhomogeneous signal intensity, oedema, necrosis, haemorrhage, fascial penetration, bone
changes and neurovascular involvement. A correct histological diagnosis is reached on the basis of
imaging studies alone in 65% to 75% of cases. The sensitivity for a MRI diagnosis of malignant
tumour was 95% and specificity was 84%.
Conclusion: Differentiation of malignant from benign lesions of musculoskeletal system is best
made by a combination of clinical and imaging parameters rather than by any single MR
characteristic. When a lesion has a non-specific MR imaging appearance, it is useful to formulate a
suitably ordered differential diagnosis based on tumour prevalence, patient age, and anatomic
location. A systematic approach markedly improves diagnostic results.
Background
The determination of the anatomical extent, characteris-
tics, and histopathological features of bone tumors and
soft-tissue sarcomas involves a diagnostic strategy in
which a biopsy is the final step [1]. MRI, however, is usu-
ally the best imaging system for the evaluation of a soft-
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involvement by a bone tumor [2]. MRI demonstrates the
depth, size, and local extent of tumours. Published opin-
ions regarding the value of MR imaging in characterizing
the pathologic nature of musculoskeletal masses and dis-
criminating between benign and malignant lesions are
divergent. There is a wide range of specificity values of MR
imaging in differentiation of benign from malignant mus-
culoskeletal lesions reported in the literature. Berquist et
al. in 1990 [3] and Moulton et al. in 1995 [4] found a rel-
atively high specificity of 76%-90%. Other researchers
have reported that MR imaging has low specificity in dif-
ferentiation between benign and malignant masses, and
most lesions demonstrate a nonspecific appearance [5].
Thus, the role of MRI in predicting malignancy has been
inadequately studied in literature and here we venture to
find out suitable imaging characteristics or a combination
of them for prediction of malignancy and to compare
whether the diagnosis made on MRI correlates with the
histopathological/cytological diagnosis.
Methods
The study included 50 patients that came from the depart-
ment of Orthopaedics or Casualty during the period from
October 2006 to September 2008, presenting with pain, a
localized swelling in the limb or inability to use the limb,
which seemed to be arising from the subcutaneous/mus-
cle plane or underlying bone on preliminary clinical
examination. Patients with superficial lesions, in which a
definite diagnosis was possible on clinical grounds e.g.
abscess were excluded from the study. The study was
approved by the ethical committee of the hospital and
written and informed consent was taken from the
patients/attendants. Following detailed physical examina-
tion (including local examination of the swelling, vitals,
systemic examination with emphasis on musculoskeletal
system evaluation); they were subjected to MR examina-
tion on 1.5 T superconducting system (MAGNETOM
Avanto, Siemens). T1W & STIR images were obtained in a
sagittal or coronal plane, for accurate determination of
longitudinal extent of tumour. Later, T2W & post-contrast
T1W images were obtained in axial planes. Other
sequences like GRE were obtained, as and when required.
Diagnoses were confirmed with histopathological exami-
nation. Various MR imaging characteristics of benign and
malignant musculoskeletal tumours were identified and
they were evaluated prospectively for their role in predic-
tion of malignancy. These characterstics included size of
tumour, shape and lobulation, margination, signal inten-
sity on T1 and T2 weighted sequences, enhancement pat-
tern, homogenous or heterogenous appearance,
peritumoral edema, presence of necrosis and calcification,
fluid-fluid level, neurovascular involvement etc.
Results
Out of the 50 patients included in the study, 32 (64%)
were males and 18 (36%) were females. The age-range of
patients included in this study was from 11 to 80 (Table
1). The proportion of benign and malignant tumours con-
firmed on histopathological evaluation was 52% (26) and
48% (24) respectively. Of these tumours seemed to be
arising from bone in 32 (64%) and from soft tissue in 18
(36%) cases. Malignant tumours were seen in 19 out of 32
male patients (59%) and 5 out of 18 female patients
(28%). The MR imaging characteristics included in this
study with their respective sensitivity and specificity are
tabulated in Table 2. A number of features were associated
with a benign diagnosis, including size less than 8 cm,
sharp margination, homogeneous T2 signal, absence of
edema, and absence of necrosis or calcification and fluid-
fluid levels (FFLs). Similarly, malignant tumours are com-
monly associated with size more than 8 cm, irregular mar-
gins (Figure 1), inhomogeneous signal (Figure 2), and
presence of edema (Figure 3), necrosis (Figure 4), hemor-
rhage (Figure 5), fascial penetration, bone changes and
neurovascular involvement. MRI diagnosis of the tumor
as benign or malignant was made subjectively based on a
combination of MRI features, tumor prevalence and loca-
tion of tumor as well as patient's age and sex. Three senior
radiologists made the diagnosis and in cases of contradic-
tion, the diagnosis was made based on majority decision.
A correct diagnosis is reached on the basis of imaging
studies alone in 65% to 75% of cases (Figure 6). The MRI
diagnosis & final diagnosis were compared and the results
are tabulated in Table 3.
Discussion
Overall prevalence of malignant musculoskeletal tumours
is estimated between 5.1 and 15.5% of all sarcomas [6]. In
our study the relatively high number (n = 24, 48%) of
malignant lesions was due to a selection bias caused by
the referral policy including only patients who had an MR
Table 1: Demographics of Subjects
Age Group Benign Malignant Grand Total
11-20 8 11 19
21-30 7 5 12
31-40 4 3 7
41-50 4 3 7
51-60 1 2 3
71-80 2 0 2
Grand Total 26 24 50Page 2 of 7
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lesions treated without imaging and of typically benign
"do not touch" lesions. The low overall prevalence rate of
musculoskeletal tumours is probably due to the fact that
the referring centres are requested to send all musculoskel-
etal tumours (benign and malignant) to the national reg-
istry.
In our study, among the morphological characteristics,
size criteria of >6 cm and >8 cm yielded a sensitivity of
95% and 75% respectively. However, size criteria of >8 cm
had a specificity of 76% while >6 cm had a specificity of
57%. Irregular and lobulated shapes of the tumors had a
sensitivity and specificity of 83% and 76% respectively.
Irregular and infiltrative margins (Figure. 1) had a sensi-
tivity and specificity of 91% and 65% respectively. Ber-
quist et al in 1990 [3] conducted a study on 95
consecutive patients with soft tissue mass lesions and
observed that 87% of malignant tumours were larger than
5 cm. 85% of malignant tumours had irregular margins.
Moulton et al in 1995 [4] showed that size criteria of >5
cm had a sensitivity of 85% and irregular margins had a
sensitivity of 74%. So these morphologic characteristics
have varied sensitivities in various studies and cannot be
reliably used for differentiating benign from malignant
tumours. Benign lesions tend to have well defined mar-
Table 2: Statistical values of various MRI features in prediction of malignancy
S.n Criterion Sensitivity Specificity PPV NPV
1. Size > 6 cm 0.95 0.57 0.67 0.93
2. Size >8 cm 0.75 0.76 0.75 0.76
3. Shape: irregular, lobulated 0.83 0.76 0.76 0.83
4. Margins: infiltrative 0.91 0.65 0.70 0.89
5. Isointensity on T1W 0.70 0.76 0.73 0.74
6. Slight hyperintensity on T2W 0.95 0.38 0.58 0.90
7. heterogeneous lesion 1 0.5 0.64 1
8. Peritumoral edema 0.95 0.5 0.63 0.92
9. Absence of multiplicity 0.54 0.15 0.37 0.26
10. Intratumoral necrosis 0.87 0.84 0.84 0.88
11. Intratumoral hemorrhage 0.70 0.65 0.65 0.70
12. Intratumoral calcification 0.70 0.88 0.85 0.76
13. Absence of Intratumoral fat 1 0.07 0.5 1
14. Absence of Intratumoral fibrosis 0.87 0.03 0.45 0.25
15. Fascia penetration 0.83 0.73 0.82 0.74
16. Bone changes 0.83 0.84 0.83 0.84
17. Neurovascular involvement 0.83 0.88 0.86 0.85
18. Enhancement pattern (Heterogenous) 1 0.07 0.5 1
19. Absence of T1 hyperintense tracts 1 0.11 0.51 1
20. Absence of Fluid-fluid levels 0.83 0.26 0.51 0.63Page 3 of 7
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ances that aid in their differentiation from malignant
processes [7]. In our study, 'Heterogeneous appearance' of
the tumour (Figure. 2) had a sensitivity and specificity of
100% and 50% respectively. 'Presence of peritumoral
edema' (Figure. 3) had a sensitivity and specificity of 95%
and 50% respectively. These characteristics are highly sen-
sitive, but the specificity is too low to be considered relia-
ble differentiating factors. De Schepper et al in 1992 [8]
noted inhomogeneous signal in 88% of malignant
tumours. He had reported highest sensitivity for "absence
of low signal intensity on T2" (100%). Pang et al, in 2003
[9] demonstrated that statistically significant imaging fea-
tures favouring a diagnosis of malignancy included inho-
mogeneity on T2-weighted images (p = 0.002) and a
change in pattern from homogeneity on T1-weighted
images to inhomogeneity on T2-weighted images (p =
0.003). Brüning et al, in 1993 [10] evaluated the inci-
dence, quantity, and presentation of intra- and extraos-
seous edema accompanying benign and malignant
primary bone lesions. The mere presence and quantity of
marrow and soft tissue edema are unreliable indicators of
the biologic potential of a lesion [10]. Golfieri et al in
1991 [11] studied the MR morphologic appearance of pri-
mary bone tumors correlated with pathologic examina-
tions and observed that peritumoral soft tissue edema was
found by STIR sequence only in malignant tumors. Crim
et al. in 1992 [12] and Griffiths et al. in 1993 [13] also
studied the morphologic characteristics of tumours and
observed that the majority of both benign and malignant
masses had inhomogeneous signal intensity and at least
partially irregular borders and MR imaging can be used to
evaluate the extent of soft-tissue masses, but most masses
will require biopsy to determine if they are benign or
malignant.
Post-contrast T1 fat saturated (FS) axial image of upper thigh shows irregular infiltr ive margins of the malignant fib ous histio ytomaFigure 1
Post-contrast T1 fat saturated (FS) axial image of 
upper thigh shows irregular infiltrative margins of the 
malignant fibrous histiocytoma.
Post-contrast T1 FS sagittal image of upper leg shows hetero-geneous nature of the malignant giant cell tumourFigure 2
Post-contrast T1 FS sagittal image of upper leg shows 
heterogeneous nature of the malignant giant cell 
tumour.
STIR coronal image of leg shows gross peritumoral edema in a patient with osteoid osteoma of tibiaFigure 3
STIR coronal image of leg shows gross peritumoral 
edema in a patient with osteoid osteoma of tibia.
Table 3: Specific diagnoses made or suspected on the basis of MR 
imaging
MRI Diagnosis Final diagnosis
Benign Malignant Total
Benign 22 1 23
Malignant 4 23 27
Grand Total 26 24 50Page 4 of 7
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necrosis' (Figure. 4) had a sensitivity and specificity of
87% and 84% respectively. 'Intratumoral hemorrhage'
(Figure. 5) had a sensitivity and specificity of 70% and
65% respectively. 'Intratumoral calcification' had a sensi-
tivity and specificity of 70% and 88% respectively. The
comparatively decreased specificity of 'Intratumoral hem-
orrhage' is due to large number of aneurysmal bone cysts
in the study. Hemorrhage or edema or both were observed
in 64% of malignant tumours [1]. Hemorrhage was noted
in 57% of malignant tumours [4]. Alyas et al in 2007 [14]
studied prevalence and diagnostic significance of fluid-
fluid levels in soft-tissue neoplasms and found that the
presence of FFLs does not reliably distinguish benign from
malignant neoplasms, although all lesions with more
than two-thirds FFLs were benign. Other imaging param-
eters which are directly related to the aggressive nature of
the tumour like 'fascia penetration', 'bone erosion' and
neurovascular involvement had high specificity and sensi-
tivity in the order of 88% and 81% respectively. These val-
ues are comparable with the values derived in other
prospective and retrospective studies conducted earlier
[3,4]. The highest sensitivity and specificity combination
was observed for neurovascular involvement, Intratu-
moral necrosis, bone erosion or invasion and fascia pene-
tration. Enhancement pattern, particularly, heterogenous
pattern of enhancement was very helpful in making the
diagnosis. The maximum sensitivity was observed for 'het-
erogeneous appearance' of malignant tumours. The maxi-
mum specificity was observed for 'neurovascular
involvement'. In our study, we had classified the tumours
into benign and malignant based on imaging parameters
described above. Then these diagnoses were correlated
with histopathological diagnosis of a benign or malignant
tumor. The MRI diagnosis & final diagnosis were com-
pared (Please refer to Table 3). Retrospective studies on
the differentiation of malignant from benign muscu-
loskeletal tumours by MR imaging largely outnumber
prospective ones. De Schepper et al. in 1992 [8] per-
formed retrospectively a multivariate statistical analysis to
determine the accuracy of ten parameters, individually
and in combination, for predicting malignancy. A sensi-
tivity and specificity of 81% was achieved when a combi-
nation of parameters was used.
Prospective studies by Ma et al., 1995, [15] Berquist et al.,
1990 [3] and Moulton et al., 1995, [4] respectively, a sen-
sitivity of 100, 94 and 78% and a specificity of 17, 90 and
89% for predicting malignancy were reported. The high
sensitivity (100%) in the study of Ma et al. coincides with
a very low specificity (17%) caused by a rigorous thresh-
Coronal T2WI image of pelvis shows fluid -fluid levels with evide ce of hemorrhagic foci in a patient with an urysmal bon  cyst of ischiopubic ram iFigure 5
Coronal T2WI image of pelvis shows fluid -fluid levels 
with evidence of hemorrhagic foci in a patient with 
aneurysmal bone cyst of ischiopubic ramii.
Bar Diagram showing the various percentage of diagnosis reached with MRI a d Combination of modalitiesFigure 6
Bar Diagram showing the various percentage of diag-
nosis reached with MRI and Combination of modali-
ties.
Post-contrast T1 FS coronal image of leg shows evidence of intratumo l necrosisFigure 4
Post-contrast T1 FS coronal image of leg shows evi-
dence of intratumoral necrosis.Page 5 of 7
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nant lesions, avoiding all false negatives. The additional
value of MRI for differentiating benign from malignant
lesions in these circumstances is doubtful. In most previ-
ous studies, the accuracy of MRI was evaluated by using a
combination of quantitative parameters. In a retrospective
study of 44 cases, however, Teo et al. in 2000, [16] con-
cluded that malignant soft tissue masses are reliably dis-
tinguished from hemangioma by subjective analysis
combining lesion morphology, signal intensity and
enhancement after gadolinium chelate injection. The sub-
jective method for the differentiation of malignant from
benign musculoskeletal tumours is also supported by Ber-
quist et al [3]. They could not identify any quantitative cri-
terion or combination of criteria that could differentiate
benign from malignant musculoskeletal tumours with
greater accuracy than on subjective evaluation. In our
study, analysis of different imaging characteristics was
performed in order to obtain a specific diagnosis or differ-
ential diagnosis with a maximum of three possibilities but
basically differentiating the possibility of benign and
malignant lesion. The patient's age, sex and clinical pres-
entation were also used. We used imaging characteristics
as described in the methods section, but also considered
tumor prevalence, location, age of the patient and con-
comitant diseases in establishing the diagnosis. Com-
pared to the study of Moulton, [4] our study, showed that
MRI reliably identifies malignancy in musculoskeletal
tumours with a higher sensitivity (95.83 vs. 78%) with
high negative predictive value (NPV) (95%) and compa-
rable specificity (84 vs. 87%), but with rather high posi-
tive predictive value (PPV) (85%). Better sensitivity was
probably the result of a methodology adapted to clinical
radiological practice (three diagnostic possibilities in our
study and only one MRI diagnosis in Moulton's study),
progress in radiological science with inclusion of newly
described parameters, description of larger series of
tumors with specific imaging characteristics and the diag-
nostic skill of radiologists. A large prospective study
showed that differentiating malignant from benign
lesions in these tumours is best achieved by using a com-
bination of clinical and imaging parameters rather than
by any single MRI feature [4].
Gielen et al performed a prospective non-quantified MR
parameter evaluation in patients with soft tissue tumors.
It showed that differentiation between malignant and
benign lesions (dignity), a sensitivity of 93%, specificity
of 82%, negative predictive value (NPV) of 98% and pos-
itive predictive value (PPV) of 60% with accuracy of 85%.
For benign lesions the sensitivity was 75% and for malig-
nant lesion it was 37%. A correct diagnosis was proposed
in 50% of the cases which was later confirmed on histopa-
thology [17].
Rijswijk et al observed that the use of combined nonen-
hanced static and dynamic contrast-enhanced MR imag-
ing demonstrated the finest diagnostic performance in the
prediction of soft-tissue tumors [18]. Contrast-enhanced
MR imaging parameters that favored malignancy were liq-
uefaction, early dynamic enhancement (within 6 seconds
after arterial enhancement), peripheral or inhomogene-
ous dynamic enhancement, and rapid initial dynamic
enhancement followed by a plateau or washout phase
[18]. They addressed the controversial issue of routine use
of contrast agent in mucsuloskeletal tumors with the
point that it, gadopentetate dimeglumine greatly
improved not only the detection of benign lesion but also
malignant lesions [18].
Conclusion
No single characteristic consistently allowed distinction
of benign from malignant tumors. Malignancy is pre-
dicted with the highest sensitivity when lesions have high
signal intensity on T2-weighted images, larger than 6 cm
diameter, have heterogeneous signal intensity on T1-
weighted images and have peritumoral edema. The high-
est specificity is noted when lesions show tumor necrosis,
bone or neurovascular involvement and mean diameter
of more than 8 cm. When a lesion has a non-specific MR
imaging appearance, it is useful to formulate a suitably
ordered differential diagnosis based on tumour preva-
lence, patient age, and anatomic location. A systematic
approach markedly improves diagnostic results.
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